![Alexzander Samuelsson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Alexzander Samuelsson
Direttore/Membro del Consiglio presso
HAVN LIFE SCIENCES INC.
Profilo
Alexzander Samuelsson is the founder of Development Catalyst Strategy Corp., founded in 2016, holding the titles of President & Chief Science Officer.
Current jobs include Director at HAVN Life Sciences, Inc. since 2022 and Chief Science Officer at Melabis, Inc. since 2019.
Former job includes Director at Right Season Investments Corp.
from 2019 to 2020.
Education includes an undergraduate degree from Toronto Metropolitan University, conferred in 2014.
Posizioni attive di Alexzander Samuelsson
| Società | Posizione | Inizio |
|---|---|---|
| HAVN LIFE SCIENCES INC. | Direttore/Membro del Consiglio | 14/10/2022 |
Melabis, Inc. | Direttore Tecnico/Scientifico/R&S | 01/06/2019 |
Development Catalyst Strategy Corp. | Fondatore | 01/01/2016 |
Precedenti posizioni note di Alexzander Samuelsson
| Società | Posizione | Fine |
|---|---|---|
| FUTUREGEN INDUSTRIES CORP. | Direttore/Membro del Consiglio | 20/04/2020 |
Formazione di Alexzander Samuelsson
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
7
Relazioni di 1° grado
5
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
Right Season Investments Corp.
 Right Season Investments Corp. MiscellaneousMiscellaneous Operates as an investment issuer focused on investing growth capital into private and public companies | Miscellaneous |
Toronto Metropolitan University of
 Toronto Metropolitan University of Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
HAVN Life Sciences, Inc.
 HAVN Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company and manufactures therapeutics | Health Technology |
Melabis, Inc. | |
Development Catalyst Strategy Corp. |
